-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Sabra Health Care REIT, Raises Price Target to $22

Benzinga·03/26/2026 14:59:48
Listen to the news
Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overweight and raises the price target from $21 to $22.